Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
When injected in a biological milieu, a nanomaterial rapidly adsorbs biomolecules forming a biomolecular corona. The biomolecular corona changes the interfacial composition of a nanomaterial giving it a biological identity that determines the physiological response. Characterization of the biomolecular structure and composition has received increasing attention mostly due to its detrimental impact on the nanomaterial's metabolism in vivo. It is generally accepted that an opsonin-enriched biomolecular corona promotes immune system recognition and rapid clearance from circulation. Here we applied dynamic light scattering and nanoliquid chromatography tandem mass spectrometry to thoroughly characterize the biomolecular corona formed around lipid and silica nanoparticles (NPs). Incubation with human plasma resulted in the formation of NP-biomolecular coronas enriched with immunoglobulins, complement factors, and coagulation proteins that bind to surface receptors on immune cells and elicit phagocytosis. Conversely, we found that protein-coated NPs were protected from uptake by macrophage RAW 264.7 cells. This implies that the biomolecular corona formation provides a stealth effect on macrophage recognition. Our results suggest that correct prediction of the NP's fate in vivo will require more than just the knowledge of the biomolecular corona composition. Validation of efficient methods for mapping protein binding sites on the biomolecular corona of NPs is an urgent task for future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study reported that the biomolecular corona formation with a specific composition provides a stealth effect on the macrophage recognition40.”
From Cloaking nanoparticles with protein corona shield for targeted drug delivery. (2018) · cites this paper as [40]
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Provencher, S. W. (1982) · Computer Physics Communications · doi:10.1016/0010-4655(82)90174-6 · Cited by 2,738
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Research works printed but not linked: 2
- 10.1021/ja107583h · DOI · Paper page
- 10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.3.CO;2-B · doi:10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.3.co;2-b
Cited by
The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine
Cai, R., & Chen, C. (2019) · Advanced Materials · doi:10.1002/adma.201805740 · Cited by 589
Biocompatibility of nanomaterials and their immunological properties
Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., et al. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe5fa · Cited by 389
“As a potential way to evade this phenomenon, it has been shown that corona formation on silica NPs provided a stealth effect on macrophage recognition [211, 212].”
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00166 · Cited by 390
“On the contrary, in a study by Caracciolo et al. (2015) in which PCs were enriched in opsonins, their uptake by macrophages after PC assembly was markedly reduced compared to bare NPs.”
ResultCloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh, J. Y., Kim, H. S., Palanikumar, L., Go, E. M., Jana, B., Park, S. A., Kim, H. Y., Kim, K., Seo, J. K., Kwak, S. K., et al. (2018) · Nature communications · doi:10.1038/s41467-018-06979-4 · Cited by 409
Ban, Z., Yuan, P., Yu, F., Peng, T., Zhou, Q., & Hu, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919755117 · Cited by 313
Nanoparticle protein corona: from structure and function to therapeutic targeting
Bashiri, G., Padilla, M. S., Swingle, K. L., Shepherd, S. J., Mitchell, M. J., & Wang, K. (2023) · Lab on a Chip · doi:10.1039/d2lc00799a · Cited by 296
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Tonigold, M., Simon, J., Estupiñán, D., Kokkinopoulou, M., Reinholz, J., Kintzel, U., Kaltbeitzel, A., Renz, P., Domogalla, M. P., Steinbrink, K., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0171-6 · Cited by 289
Interplay of protein corona and immune cells controls blood residency of liposomes
Giulimondi, F., Digiacomo, L., Pozzi, D., Palchetti, S., Vulpis, E., Capriotti, A. L., Chiozzi, R. Z., Laganà, A., Amenitsch, H., Masuelli, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11642-7 · Cited by 264
Self-citationEmerging understanding of the protein corona at the nano-bio interfaces
Mahmoudi, M., Bertrand, N., Zope, H., & Farokhzad, O. C. (2016) · Nano Today · doi:10.1016/j.nantod.2016.10.005 · Cited by 250
Protein bio-corona: critical issue in immune nanotoxicology
Neagu, M., Piperigkou, Z., Karamanou, K., Engin, A. B., Docea, A. O., Constantin, C., Negrei, C., Nikitovic, D., & Tsatsakis, A. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1797-5 · Cited by 236
“Human serum albumin and apoE are used to steadily form conjugates with polyelectrolyte multilayer-coated gold NP (AuNP) prior to intravenous injection.”
BackgroundProtein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake
Pustulka, S. M., Ling, K., Pish, S. L., & Champion, J. A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12341 · Cited by 160
Shreffler, J. W., Pullan, J. E., Dailey, K. M., Mallik, S., & Brooks, A. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236056 · Cited by 158
“While the protein corona surrounding Abraxane suppresses the burst release of paclitaxel, the protein corona surrounding Doxova compromises the integrity of the particle, potentially leading to increased circulation times, but consequently compromising cellular penetration and promoting premature release of its doxoru…”
BackgroundUnveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Strojan, K., Leonardi, A., Bregar, V. B., Križaj, I., Svete, J., & Pavlin, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169552 · Cited by 131
Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death
Xu, S., Zheng, H., Ma, R., Wu, D., Pan, Y., Yin, C., Gao, M., Wang, W., Li, W., Liu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17300-7 · Cited by 143
Tan, Y., Zhu, X., Wu, D., Song, E., & Song, Y. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c04097 · Cited by 140
Obst, K., Yealland, G., Balzus, B., Miceli, E., Dimde, M., Weise, C., Eravci, M., Bodmeier, R. A., Haag, R., Calderón, M., et al. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00158 · Cited by 143
Yu, Q., Zhao, L., Guo, C., Yan, B., & Su, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00210 · Cited by 128
Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona
Saad, M. A., Rao, C. M., & Ahmad, M. F. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-72041-8_11 · Cited by 140
Polyethylene glycol immunogenicity in nanomedicine
Chen, Y., Su, Y.-C., & Roffler, S. R. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00321-6 · Cited by 113
In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain, P., Pawar, R. S., Pandey, R. S., Madan, J., Pawar, S., Lakshmi, P. K., & Sudheesh, M. S. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.08.003 · Cited by 128
“…by macrophage Accessibility and orientation of proteins in corona may be responsible for the stealth property acquired by nanoparticles in blood Caracciolo et al. (2015), Mirshafiee et al. (2016) Preferential adsorption of ApoE has been found to be a major determinant for targeting of NPs to…”
BackgroundCancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona
Barui, A. K., Oh, J. Y., Jana, B., Kim, C., & Ryu, J. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900124 · Cited by 123
Piperigkou, Z., Καραμάνου, Κ., Engin, A. B., Gialeli, C., Docea, A. O., Vynios, D. H., Pavão, M. S. G., Golokhvast, K. S., Shtilman, M. I., Argiris, A. E., et al. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.003 · Cited by 117
Effects of the protein corona on liposome–liposome and liposome–cell interactions
Tasciotti, E., Molinaro, R., Taraballi, F., Furman, N. E. T., Sherman, M. B., Parodi, A., Salvatore, F., & Corbo, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s109059 · Cited by 112
“19,20 Here we report increased liposome uptake by both J774 and 4T1 cells after plasma incubation.”
Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers
Berrecoso, G., Crecente‐Campo, J., & Alonso, M. J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00745-0 · Cited by 110
Plasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
Chen, D., Ganesh, S., Wang, W., & Amiji, M. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0178 · Cited by 97
Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation
Silva, A. L., Peres, C., Conniot, J., Matos, A. I., Moura, L., Carreira, B., Sainz, V., Scomparin, A., Satchi-Fainaro, R., Préat, V., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.003 · Cited by 95
“However, when proteins like albumin or apolipoproteins are present on the protein corona, the NP internalization is inhibited [156,165].”
BackgroundUnusual zymogen activation patterns in the protein corona of Ca-zeolites
Shang, X., Chen, H., Castagnola, V., Liu, K., Boselli, L., Petseva, V., Yu, L., Xiao, L., He, M., Wang, F., et al. (2021) · Nature Catalysis · doi:10.1038/s41929-021-00654-6 · Cited by 104
Tomak, A., Çeşmeli, S., HANOĞLU, B. D., Winkler, D. A., & Karakuş, C. Ö. (2021) · Nanotoxicology · doi:10.1080/17435390.2022.2025467 · Cited by 112
“Caracciolo et al. (2015) characterized the structure and composition of the protein corona around 1,2-Dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DOPG) and silica NPs after interacting with human plasma for 60min.”
BackgroundPapi, M., Caputo, D. D., Palmieri, V., Coppola, R., Palchetti, S., Bugli, F., Martini, C., Digiacomo, L., Pozzi, D., & Caracciolo, G. (2017) · Nanoscale · doi:10.1039/c7nr03042h · Cited by 103
Self-citationWang, Z., Wang, C., Liu, S., He, W., Wang, L., Gan, J., Huang, Z. D., Wang, Z., Wei, H., Zhang, J., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b07461 · Cited by 101
Impact of the protein corona on nanomaterial immune response and targeting ability
Digiacomo, L., Pozzi, D., Palchetti, S., Zingoni, A., & Caracciolo, G. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1615 · Cited by 111
Self-citationSu, G., Jiang, H., Xu, B., Yu, Y., & Chen, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00612 · Cited by 90
Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery
Mirón-Barroso, S., Domènech, E. B., & Trigueros, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168537 · Cited by 91
“Some proteins, such as complement factors and immunoglobulins, called opsonins, can facilitate the uptake of nanoparticles by the phagocytic system leading to a decreased half-life and the activation of the immune response [90,91].”
BackgroundNanoparticles-cell association predicted by protein corona fingerprints
Palchetti, S., Digiacomo, L., Pozzi, D., Peruzzi, G., Micarelli, E., Mahmoudi, M., & Caracciolo, G. (2016) · Nanoscale · doi:10.1039/c6nr03898k · Cited by 92
Self-citationThe Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
Bros, M., Nuhn, L., Simon, J., Moll, L., Mailänder, V., Landfester, K., & Grabbe, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01760 · Cited by 93
“Likewise, immunoglobulins derived from plasma may also bind to NC, either in an epitope-specific form (thus “opsonizing” the NC) or via non-specific adsorption (76).”
BackgroundSpotlight on the protein corona of liposomes
Onishchenko, N. R., Tretiakova, D. S., & Vodovozova, E. L. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.074 · Cited by 89
Beyond the protein corona—Lipids matter for biological response of nanocarriers
Müller, J., Prozeller, D., Ghazaryan, A., Kokkinopoulou, M., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.036 · Cited by 79
“This includes, for example, the control of the formation of a “protein corona,” which has a tremendous effect on the biodistribution of nanocarriers, as it has been shown in various publications.[1-9] However, proteins are by far not the only type of biological molecules that can potentially interact with nanocarriers.”
Nanoparticles and direct immunosuppression
Ngobili, T. A., & Daniele, M. A.-A. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216650053 · Cited by 79
Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung
Zhao, J., Lu, Q., Song, R., Su, J. Q., Yuan, Y., Zhang, X., & Mao, S. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.01.009 · Cited by 78
Caracciolo, G., Palchetti, S., Digiacomo, L., Chiozzi, R. Z., Capriotti, A. L., Amenitsch, H. W., Tentori, P. M., Palmieri, V., Papi, M., Cardarelli, F., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04962 · Cited by 73
Self-citationCurrent Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB
Kimura, S., & Harashima, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121216 · Cited by 65
Protein corona, influence on drug delivery system and its improvement strategy: A review
Guo, F., Luo, S., Wang, L., Wang, M., Wu, F., Wang, Y., Jiao, Y., Du, Y., Yang, Q., Yang, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128513 · Cited by 75
Stealth Immune Properties of Graphene Oxide Enabled by Surface-Bound Complement Factor H
Belling, J. N., Jackman, J. A., Avsar, S. Y., Park, J. H., Wang, Y., Potroz, M. G., Ferhan, A. R., Weiss, P. S., & Cho, N. (2016) · ACS Nano · doi:10.1021/acsnano.6b05409 · Cited by 68
The biomolecular corona of gold nanoparticles in a controlled microfluidic environment
Digiacomo, L., Palchetti, S., Giulimondi, F., Pozzi, D., Chiozzi, R. Z., Capriotti, A. L., Laganà, A., & Caracciolo, G. (2019) · Lab on a Chip · doi:10.1039/c9lc00341j · Cited by 61
Self-citationProtein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation
Debnath, M., Forster, J., Ramesh, A., & Kulkarni, A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00329 · Cited by 60
Buoyant Nanoparticles: Implications for Nano‐Biointeractions in Cellular Studies
Watson, C., DeLoid, G. M., Pal, A. K., & Demokritou, P. (2016) · Small · doi:10.1002/smll.201600314 · Cited by 54
Li, Z., Wang, Y., Zhu, J., Zhang, Y., Zhang, W., Zhou, M., Luo, C., Li, Z. J., Cai, B., Gui, S., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.007 · Cited by 51
Assessing inorganic nanoparticle toxicity through omics approaches
Li, Y., Vulpe, C. D., Lammers, T., & Pallares, R. M. (2024) · Nanoscale · doi:10.1039/d4nr02328e · Cited by 51
Emerging nanotaxanes for cancer therapy
Zhang, Y., Zhang, W., Wang, Y., Zhu, J., Zhou, M., Peng, C., He, Z., Sun, J., Li, Z., & Gui, S. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120790 · Cited by 49
Biomolecular corona formation on CuO nanoparticles in plant xylem fluid
Borgatta, J. R., Reardon-Lochbaum, C. A., Elmer, W. H., White, J. C., Pedersen, J. A., & Hamers, R. J. (2021) · Environmental Science Nano · doi:10.1039/d1en00140j · Cited by 60
Chen, R., & Riviere, J. E. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1440 · Cited by 49
Li, Z., Li, D., Li, Q., Luo, C., Li, J., Kou, L., Zhang, D., Zhang, H., Zhao, S., Kan, Q., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm00692j · Cited by 47
Lübtow, M. M., Keßler, L., Appelt‐Menzel, A., Lorson, T., Gangloff, N., Kirsch, M., Dahms, S., & Luxenhofer, R. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800155 · Cited by 40
Devineau, S., Zargarian, L., Renault, J., & Pin, S. (2017) · Langmuir · doi:10.1021/acs.langmuir.6b04281 · Cited by 43
“The protein corona determines the NM uptake and its biological outcome 29–31 .”
BackgroundDar, A. I., Randhawa, S., Verma, M., Saini, T. C., & Acharya, A. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103535 · Cited by 42
Interplay between nanomedicine and protein corona
Yang, M., Wu, E., Tang, W., Qian, J., & Zhan, C. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01063h · Cited by 40
Exploitation of nanoparticle–protein corona for emerging therapeutic and diagnostic applications
Palchetti, S., Pozzi, D., Mahmoudi, M., & Caracciolo, G. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01095d · Cited by 36
Self-citationA decade of the liposome-protein corona: Lessons learned and future breakthroughs in theranostics
Quagliarini, E., Digiacomo, L., Renzi, S., Pozzi, D., & Caracciolo, G. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101657 · Cited by 39
Self-citationBao, J., Zhang, Q., Duan, T., Hu, R., & Tang, J. (2021) · Current Drug Targets · doi:10.2174/1389450122666210118105122 · Cited by 38
Jasinski, J., Wilde, M. V., Völkl, M., Jérôme, V., Fröhlich, T., Freitag, R., & Scheibel, T. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c13987 · Cited by 37
Silica-based nanoparticles as drug delivery systems
Karaman, D. Ş., & Kettiger, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00001-8 · Cited by 42
Artificial protein coronas: directing nanoparticles to targets
Caracciolo, G. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.05.003 · Cited by 46
Self-citationInfluence of the polymer type of a microplastic challenge on the reaction of murine cells
Jasinski, J., Völkl, M., Wilde, M. V., Jérôme, V., Fröhlich, T., Freitag, R., & Scheibel, T. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133280 · Cited by 30
Machová, I., Hubálek, M., Bělinová, T., Fučíková, A., Stehlík, Š., Rezek, B., & Kalbáčová, M. H. (2020) · Carbon · doi:10.1016/j.carbon.2020.02.061 · Cited by 30
Gerasimovich, E. S., Karaulov, A. V., Nabiev, I. R., & Sukhanova, A. V. (2025) · Nanomaterials · doi:10.3390/nano15131013 · Cited by 32
“The formation of a protein corona on lipid and silica NPs reduced their uptake by RAW 264.7 macrophages [164].”
InfluentialGuindani, C., Frey, M., Simon, J., Koynov, K., Schultze, J., Ferreira, S. R. S., de Araújo, P. H. H., de Olíveira, D., Wurm, F. R., Mailänder, V., et al. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900145 · Cited by 31
CE Separation and ICP-MS Detection of Gold Nanoparticles and Their Protein Conjugates
Legat, J., Matczuk, M., Timerbaev, A. R., & Jarosz, M. (2017) · Chromatographia · doi:10.1007/s10337-017-3387-y · Cited by 29
Revisiting the outstanding questions in cancer nanomedicine with a future outlook
Sudheesh, M. S., Pavithran, K., & Sabitha, M. (2021) · Nanoscale Advances · doi:10.1039/d1na00810b · Cited by 27
Cao, Y., Wei, Z., Li, M., Wang, H., Yin, L., Chen, D., Wang, Y., Chen, Y., Yuan, Q., Pu, X., et al. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180629150927 · Cited by 26
Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design
Liu, K., Salvati, A. L., & Sabirsh, A. (2022) · Nanoscale · doi:10.1039/d1nr08101b · Cited by 26
Iscaro, J., Yu, H., Martínez, N. P., Subramaniam, S., Joyce, P. M., Wang, H., Dyett, B., White, J., Prestidge, C. A., Drummond, C. J., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202405286 · Cited by 29
Brückner, M., Simon, J., Jiang, S., Landfester, K., & Mailänder, V. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.041 · Cited by 24
Ferenc, M., Katir, N., Miłowska, K., Bousmina, M., Brahmi, Y., Felczak, A., Lisowska, K., Bryszewska, M. J., & Kadib, A. E. (2016) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2016.05.012 · Cited by 24
Sánchez-Arribas, N., Martínez‐Negro, M., Villar‐Álvarez, E., Pérez, L., Aicart, E., Taboada, P., Guerrero‐Martínez, A., & Junquera, E. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c06273 · Cited by 24
der Sanden, N. V., Paun, R. A., Yitayew, M. Y., Boyadjian, O., & Tabrizian, M. (2024) · Nanoscale Advances · doi:10.1039/d4na00783b · Cited by 30
Interactions of nanoparticles with living and synthetic bio-membranes
Kariuki, R., Mirihana, K. A., Penman, R., Hung, A., Meftahi, N., Bryant, G., Ramsland, P. A., Voïtchovsky, K., Conn, C. E., Contini, C., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00841g · Cited by 26
Nanoparticle–proteome in vitro and in vivo
Wang, M., Gustafsson, O., Pilkington, E. H., Käkinen, A., Javed, I., Faridi, A., Davis, T. P., & Ke, P. C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01634h · Cited by 25
Kavok, N. S., Grygorova, G. V., Klochkov, V., & Yefimova, S. L. (2017) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2017.06.052 · Cited by 24
Martínez‐Negro, M., Caracciolo, G., Palchetti, S., Pozzi, D., Capriotti, A. L., Cavaliere, C., Laganà, A., Mellet, C. O., Benito, J. M., Fernández, J. M. G., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.03.010 · Cited by 21
Self-citationIns and Outs in Environmental and Occupational Safety Studies of Asthma and Engineered Nanomaterials
Dobrovolskaia, M. A., Shurin, M. R., Kagan, V. E., & Shvedova, A. A. (2017) · ACS Nano · doi:10.1021/acsnano.7b04916 · Cited by 21
Silicon Quantum Dots and Their Impact on Different Human Cells
Bělinová, T., Vrabcová, L., Machová, I., Fučíková, A., Valenta, J., Sugimoto, H., Fujii, M., & Kalbáčová, M. H. (2018) · physica status solidi (b) · doi:10.1002/pssb.201700597 · Cited by 21
Protein corona variation in nanoparticles revisited: A dynamic grouping strategy
Rezaei, G., Daghighi, S. M., Haririan, I., Yousefi, I., Raoufi, M., Rezaee, F., & Dinarvand, R. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.003 · Cited by 22
Spinelli, L., D’Anna, P., Morretta, E., Cassiano, C., Piccolo, V., Rosa, M. D., Amico, R., Cicco, P. D., Brancaccio, D., Conte, C., et al. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c01369 · Cited by 21
Quagliarini, E., Santo, R. D., Palchetti, S., Ferri, G., Cardarelli, F., Pozzi, D., & Caracciolo, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020113 · Cited by 21
“On the other side, PC can have a stealth effect on NP uptake by immune cells [40].”
BackgroundSelf-citationTargeted and theranostic applications for nanotechnologies in medicine
Setua, S., Jaggi, M., Yallapu, M. M., Chauhan, S. C., Aleksandrovna, D. A., Lee, H., Choi, I. S., Fakhrullin, R. F., Esposti, L. D., Tampieri, A., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00006-x · Cited by 26
Sharma, P., Sen, D., Neelakantan, V., Shankar, V., & Jhunjhunwala, S. (2019) · Biomaterials Science · doi:10.1039/c8bm01545g · Cited by 20
Kim, J., & Doudrick, K. (2019) · Environmental Science Nano · doi:10.1039/c9en00130a · Cited by 18
Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers
Wagner, J. S., Dillenburger, M., Simon, J., Oberländer, J., Landfester, K., Mailänder, V., Ng, D. Y. W., Müllen, K., & Weil, T. (2020) · Chemical Communications · doi:10.1039/d0cc02486d · Cited by 19
Jang, G. J., Jeong, J. Y., Kang, J., Cho, W., & Han, S. Y. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c01182 · Cited by 19
Wang, T., Yin, L., Ma, Z., & Zhang, Y. (2022) · Molecules · doi:10.3390/molecules27041430 · Cited by 18
“In previous studies, biomolecular corona and the opsonization of complement factors on nanoparticles change the design’s original intention [35,36].”
BackgroundRole of the complement cascade in the biological fate of liposomes in rodents
Viana, I. M. D. O., Grenier, P., Defrêne, J., Barabé, F., Lima, E. M., & Bertrand, N. (2020) · Nanoscale · doi:10.1039/d0nr04100a · Cited by 18
Ge, Y., Fu, F., Gao, Y. P., He, T., Mailänder, V., Crespy, D., Landfester, K., & Jiang, S. (2025) · Advanced Science · doi:10.1002/advs.202502788 · Cited by 22
Looking back, moving forward: protein corona of lipid nanoparticles
Gao, Y., Huang, Y., Ren, C., Chou, P., Wu, C., Pan, X., Quan, G., & Huang, Z. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00186a · Cited by 17
Köse, Ö., Stalet, M., Leclerc, L., & Forest, V. (2020) · RSC Advances · doi:10.1039/d0ra08429h · Cited by 18
Fabrication of human serum albumin–imprinted photothermal nanoparticles for enhanced immunotherapy
Ma, J., Zhang, Y., Sun, H., Ding, P., & Chen, D. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00396a · Cited by 16
Saini, A., Li, S., Wang, Z., Plebanski, M., & Ju, Y. (2026) · ACS Nano · doi:10.1021/acsnano.6c00334 · Cited by 17
Brückner, M., Fichter, M., Marques, R. D. C., Landfester, K., & Mailänder, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081614 · Cited by 16
“Furthermore, the use of culture medium with and without fetal bovine serum (FBS) highlighted the role of additional proteins that can form a biomolecular corona on the nanocarrier surface, potentially influencing the nanocarrier cell interaction [36].”
BackgroundMethodPizzi, D., Nandakumar, A., Morrow, J. P., Humphries, J., Siddiqui, G., Creek, D. J., Quinn, J. F., Yin, J., Shi, Q., Cheng, W., et al. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.112964 · Cited by 15
Wen, J., Lei, C., Hua, S., Cai, L., Dai, H., Liu, S., Li, Y., Ivanovski, S., & Xu, C. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01124d · Cited by 15
Metadata
- Authors
- Caracciolo, G., Palchetti, S., Colapicchioni, V., Digiacomo, L., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A.
- Affiliations
- Sapienza University of Rome (IT)
- Italian Institute of Technology (IT)
- Università di Camerino (IT)
- Department of Chemistry, “Sapienza” University of Rome, P.le A. Moro 5, 00185 Rome, Italy
- Corresponding author
- Pozzi, Daniela
- ORCID
- Venue
- Langmuir
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-09-25
- Volume
- 31
- Issue
- 39
- Pages
- 10764-10773
- ISSN
- 0743-7463 (ISSN-L)
- 1520-5827
- OpenAlex
- W2338571857
- Cited by
- 131
- References
- 59
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 10 · 2023: 5 · 2022: 9 · 2021: 13 · 2020: 20 · 2019: 11 · 2018: 18 · 2017: 14 · 2016: 12
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Langmuir (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Ministero dell'Istruzione, dell'Università e della Ricerca (RBFR08TLPO)
- Center for Life Nano Science, Sapienza Università di Roma
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Electronic, Optical and Magnetic Materials › Gold and Silver Nanoparticles Synthesis and Applications
- Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
- Keywords
- biomolecular corona, nanoparticle uptake, macrophages, phagocytosis, opsonization, immunoglobulins, complement proteins, coagulation factors, lipid nanoparticles, silica nanoparticles, plasma protein adsorption, RAW 264.7 macrophages
- MeSH terms
- Adult, Animals, Cell Line, Chromatography, Liquid, Endocytosis, Humans, Macrophages, Mice, Tandem Mass Spectrometry, Nanoparticles, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.